← back to search

Wanyin Wu

Guangzhou University of Chinese Medicine · CN
Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research interests include Medicine, Cancer research, Apoptosis, Cell growth, Cancer, and Biology.
h-index
citations
1,881
works
44
NIH funding
primary concept
email

Recent publications

Targeting Frequent Efferocytosis in Tumor Microenvironment is a New Direction for Cancer Treatment
Small Science 2025cited by 4position: middledoi
Risk factors for brain metastasis in lung cancer: an umbrella review of systematic reviews and meta-analyses
BMJ Open 2025cited by 2position: middledoi
Efficacy and Safety of Shenyi Capsule (Ginsenoside Rg3) as Adjuvant Therapy for Cancer: An Overview of Systematic Reviews and Meta-Analyses
Integrative Cancer Therapies 2025cited by 1position: middledoi
Fuzheng Kang'ai Formula suppresses NSCLC by inducing a functional crosstalk between autophagy and ferroptosis via EZH2/DOT1L/H3K79me2 signaling
Phytomedicine 2025cited by 0position: middledoi
Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatments
Biomedicine & Pharmacotherapy 2024cited by 37position: middledoi
Treating human cancer by targeting EZH2
Genes & Diseases 2024cited by 17position: middledoi
Efficacy and Safety of Huachansu as an Adjuvant Therapy for Non-Small Cell Lung Cancer: An Overview of Systematic Reviews and Meta-Analyses
Integrative Cancer Therapies 2024cited by 5position: middledoi
Application of Traditional Chinese Medicines as Personalized Therapy in Human Cancers
WORLD SCIENTIFIC eBooks 2024cited by 1position: lastdoi
Kaempferol promotes non-small cell lung cancer cell autophagy via restricting Met pathway
Phytomedicine 2023cited by 62position: middledoi
Fuzheng Kang-Ai inhibits NSCLC cell proliferation via regulating hsa_circ_0048091/hsa-miR-378g/ARRDC3 pathway
Phytomedicine 2023cited by 15position: middledoi
The application of arsenic trioxide in cancer: An umbrella review of meta-analyses based on randomized controlled trials
Journal of Ethnopharmacology 2023cited by 15position: middledoi
Solamargine enhanced gefitinib antitumor effect via regulating MALAT1/miR-141-3p/Sp1/IGFBP1 signaling pathway in non-small cell lung cancer
Carcinogenesis 2023cited by 14position: middledoi
The complementary and alternative roles of elemene injection in cancer: An umbrella review
Pharmacological Research 2023cited by 14position: middledoi
FZKA reverses gefitinib resistance by regulating EZH2/Snail/EGFR signaling pathway in lung adenocarcinoma
Journal of Ethnopharmacology 2023cited by 13position: middledoi
Fuzheng Kang-Ai decoction increases the sensitivity of Gefitinib via inducing Non-Small Cell Lung Cancer ferroptosis through AMPK/SLC7A11 pathway
Research Square 2023cited by 0position: middledoi
The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers
Frontiers in Immunology 2022cited by 530position: middledoi
GPX4 Plays a Crucial Role in Fuzheng Kang’ai Decoction-Induced Non-Small Cell Lung Cancer Cell Ferroptosis
Frontiers in Pharmacology 2022cited by 27position: lastdoi
Efficacy and safety of Brucea javanica oil emulsion injection as adjuvant therapy for cancer: An overview of systematic reviews and meta-analyses
Phytomedicine 2022cited by 25position: lastdoi
Efficacy and Safety of Huaier Granule as an Adjuvant Therapy for Cancer: An Overview of Systematic Reviews and Meta-Analyses
Integrative Cancer Therapies 2022cited by 11position: lastdoi
GPX4 Plays a Crucial Role in Fuzheng Kang’ai Decoction-Induced Non-Small Cell Lung Cancer Cell Ferroptosis
Research Square 2022cited by 2position: lastdoi
Compound Kushen Injection Protects Skin From Radiation Injury via Regulating Bim
Frontiers in Pharmacology 2021cited by 9position: middledoi
Systematic review and meta analysis of the TCM therapy of Fuzheng and Kangai combined with chemotherapy in treating advanced NSCLC
DOAJ (DOAJ: Directory of Open Access Journals) 2021cited by 0position: last
Positive Role of Chinese Herbal Medicine in Cancer Immune Regulation
The American Journal of Chinese Medicine 2020cited by 254position: lastdoi
MicroRNA-24 in Cancer: A Double Side Medal With Opposite Properties
Frontiers in Oncology 2020cited by 29position: lastdoi
Fuzheng Kang-Ai decoction enhances the effect of Gefitinib-induced cell apoptosis in lung cancer through mitochondrial pathway
Cancer Cell International 2020cited by 15position: lastdoi
COL1A1, COL1A2, COL3A1 and DCN are Potential Biomarkers to Predict Progression from Smokers to Suffering from Lung Adenocarcinoma
2020cited by 2position: lastdoi
MicroRNAs as Therapeutic Targets in Nasopharyngeal Carcinoma
Frontiers in Oncology 2019cited by 50position: lastdoi
MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer
Cancer Letters 2019cited by 30position: middledoi
The regulation and interaction of colon cancer‐associated transcript‐1 and miR7‐5p contribute to the inhibition of SP1 expression by solamargine in human nasopharyngeal carcinoma cells
Phytotherapy Research 2019cited by 22position: middledoi
<p>Interaction Of c-Jun And HOTAIR- Increased Expression Of p21 Converge In Polyphyllin I-Inhibited Growth Of Human Lung Cancer Cells</p>
OncoTargets and Therapy 2019cited by 16position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sumei Wang · Zhejiang Provincial People's Hospital30 papers (2016–2025)Qing Tang · Sichuan University22 papers (2014–2025)Swei Sunny Hann · Guangzhou University of Chinese Medicine12 papers (2014–2019)Shunqin Long · Guangzhou University of Chinese Medicine9 papers (2018–2025)Qichun Zhou · Guangzhou University of Chinese Medicine9 papers (2023–2025)Jingjing Wu · New York University7 papers (2014–2019)Mengfei Xu · Shandong University6 papers (2023–2024)Fang Zheng · Sun Yat-sen University6 papers (2015–2019)Shuqi Chen · Guangzhou University of Chinese Medicine5 papers (2020–2023)Xinliang Wan · Guangzhou University of Chinese Medicine5 papers (2023–2025)Jixin Chen · Guangzhou University of Chinese Medicine4 papers (2020–2023)Ling Han · Fudan University4 papers (2022–2023)Xiao-Bing Yang · Iowa State University4 papers (2023–2024)Honghao Sheng · Guangzhou University of Chinese Medicine4 papers (2020–2022)Shunyu Zhao · Guangzhou University of Chinese Medicine4 papers (2014–2015)Liuning Li · Guangzhou University of Chinese Medicine4 papers (2014–2015)Jixin Chen · Guangzhou University of Chinese Medicine3 papers (2022–2025)Lijun Yang · Fudan University3 papers (2015–2016)Yueyang Zhao · Hebei Medical University3 papers (2019–2023)Xiaobing Yang · Guangzhou University of Chinese Medicine3 papers (2022–2025)